917O DS-3939, a tumor-associated mucin 1 (TA-MUC1)–directed antibody–drug conjugate (ADC), in patients (pts) with advanced/metastatic (adv/met) solid tumors: Initial results from a first-in-human (FIH) study. - Patel, M.R.; Doi, T.; Yamamoto, N.; Garrido-Laguna, I.; Nishioka, S.; Wu, S.; Ostheimer, C.; Nakajima, K.; Carneiro, B.A. (Annals of Oncology, 2025)